Home
Conditions
Lymphoma, Large B-Cell, Diffuse

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

NCT00025415

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma

NCT00002909

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Johns Hopkins Oncology Center Baltimore, Maryland, United States

View Trial Details

Completed

Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

NCT00003039

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations: Clinical Sciences Building Chicago, Illinois, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States

View Trial Details

Completed

Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00002725

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

NCT00002759

Conditions: Agranulocytosis, Burkitt Lymphoma, Chemically-Induced Disorders, +51 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

View Trial Details

Completed

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

NCT00003451

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

View Trial Details

Completed

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

NCT00016094

Conditions: Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +22 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder

NCT00064246

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +32 more
Locations: AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

NCT00098891

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +92 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse trial results

Related conditions